{"id":"https://openalex.org/W2188643397","doi":null,"title":"FORMULATION AND EVALUATION OF MOUTH DISSOLVING TABLETS OF OXCARBAZEPINE","display_name":"FORMULATION AND EVALUATION OF MOUTH DISSOLVING TABLETS OF OXCARBAZEPINE","publication_year":2009,"publication_date":"2009-01-01","ids":{"openalex":"https://openalex.org/W2188643397","mag":"2188643397"},"language":"en","primary_location":{"id":"mag:2188643397","doi":null,"is_oa":false,"landing_page_url":"http://www.ijppsjournal.com/Vol1Suppl1/201.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5049622227","display_name":"Anupama Kalia","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anupama Kalia","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005812949","display_name":"Shelly Khurana","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shelly Khurana","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5004950702","display_name":"Neena Bedi","orcid":"https://orcid.org/0000-0001-6403-6289","observed_orcids":["https://orcid.org/0000-0001-6403-6289"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Neena Bedi","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6403-6289","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.3339,"has_fulltext":false,"cited_by_count":36,"citation_normalized_percentile":{"value":0.73990698,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11881","display_name":"Crystallization and Solubility Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2505","display_name":"Materials Chemistry"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/oxcarbazepine","display_name":"oxcarbazepine","score":1.0},{"id":"https://openalex.org/keywords/mouth-dissolving-tablets","display_name":"mouth dissolving tablets","score":0.9660000205039978},{"id":"https://openalex.org/keywords/solid-dispersion","display_name":"solid dispersion","score":0.7329999804496765},{"id":"https://openalex.org/keywords/direct-compression","display_name":"direct compression","score":0.925000011920929},{"id":"https://openalex.org/keywords/antiepileptic-drugs","display_name":"antiepileptic drugs","score":0.7419999837875366},{"id":"https://openalex.org/keywords/polyvinylpyrrolidone-k30","display_name":"polyvinylpyrrolidone K30","score":0.902999997138977},{"id":"https://openalex.org/keywords/peg-6000","display_name":"polyethylene glycol 6000","score":0.9860000014305115},{"id":"https://openalex.org/keywords/crospovidone","display_name":"crospovidone","score":0.9459999799728394},{"id":"https://openalex.org/keywords/aspartame","display_name":"aspartame","score":0.7239999771118164},{"id":"https://openalex.org/keywords/drug-solubility-enhancement","display_name":"drug solubility enhancement","score":0.859000027179718},{"id":"https://openalex.org/keywords/drug-release","display_name":"drug release","score":0.8659999966621399},{"id":"https://openalex.org/keywords/dissolution-profile","display_name":"dissolution profile","score":0.6230000257492065}],"concepts":[{"id":"https://openalex.org/C2781176495","wikidata":"https://www.wikidata.org/wiki/Q176301","display_name":"Oxcarbazepine","level":4,"score":0.9152345657348633},{"id":"https://openalex.org/C2780077769","wikidata":"https://www.wikidata.org/wiki/Q413433","display_name":"Polyvinylpyrrolidone","level":2,"score":0.7738873958587646},{"id":"https://openalex.org/C88380143","wikidata":"https://www.wikidata.org/wiki/Q416674","display_name":"Dissolution","level":2,"score":0.7149832248687744},{"id":"https://openalex.org/C155574463","wikidata":"https://www.wikidata.org/wiki/Q170731","display_name":"Solubility","level":2,"score":0.5434473156929016},{"id":"https://openalex.org/C2778278337","wikidata":"https://www.wikidata.org/wiki/Q182040","display_name":"Aspartame","level":2,"score":0.46957892179489136},{"id":"https://openalex.org/C77281830","wikidata":"https://www.wikidata.org/wiki/Q718608","display_name":"Dosage form","level":2,"score":0.4576534032821655},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.441250205039978},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.44085240364074707},{"id":"https://openalex.org/C177562468","wikidata":"https://www.wikidata.org/wiki/Q182893","display_name":"Dispersion (optics)","level":2,"score":0.4367656111717224},{"id":"https://openalex.org/C42360764","wikidata":"https://www.wikidata.org/wiki/Q83588","display_name":"Chemical engineering","level":1,"score":0.35517382621765137},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3245033621788025},{"id":"https://openalex.org/C2779253243","wikidata":"https://www.wikidata.org/wiki/Q410412","display_name":"Carbamazepine","level":3,"score":0.17478641867637634},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.17337799072265625},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.13614436984062195},{"id":"https://openalex.org/C188027245","wikidata":"https://www.wikidata.org/wiki/Q750446","display_name":"Polymer chemistry","level":1,"score":0.07264557480812073},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.055091530084609985},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.0},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2188643397","doi":null,"is_oa":false,"landing_page_url":"http://www.ijppsjournal.com/Vol1Suppl1/201.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":20,"referenced_works":["https://openalex.org/W52651026","https://openalex.org/W1573521801","https://openalex.org/W1973761845","https://openalex.org/W1983521939","https://openalex.org/W1991054319","https://openalex.org/W1993464685","https://openalex.org/W1993909919","https://openalex.org/W2008223612","https://openalex.org/W2015642821","https://openalex.org/W2020046777","https://openalex.org/W2036103157","https://openalex.org/W2047846970","https://openalex.org/W2074174052","https://openalex.org/W2089053051","https://openalex.org/W2090130799","https://openalex.org/W2134187860","https://openalex.org/W2141210044","https://openalex.org/W2150508695","https://openalex.org/W2255262875","https://openalex.org/W2283449839"],"related_works":["https://openalex.org/W1969158267","https://openalex.org/W2765431163","https://openalex.org/W2183999134","https://openalex.org/W2493530139","https://openalex.org/W7217749159","https://openalex.org/W4401493621","https://openalex.org/W2804427913","https://openalex.org/W2810387808","https://openalex.org/W4378901328","https://openalex.org/W2893390422"],"abstract_inverted_index":{"Oxcarbazepine":[0,128],"is":[1,25],"an":[2,8],"anticonvulsant":[3],"drug,":[4],"mainly":[5],"used":[6],"as":[7,95,100],"add-on":[9],"or":[10],"first":[11],"line":[12],"treatment":[13],"in":[14,114,134],"adults":[15],"and":[16,64,83,98,110,144,179,181],"children.":[17],"Due":[18],"to":[19,27,48,123,174,192,195],"sudden":[20],"onset":[21],"of":[22,52,59,105,137],"attack,":[23],"it":[24],"necessary":[26],"formulate":[28],"antiepileptics":[29],"into":[30,151],"such":[31],"a":[32,46,56,96,101,121],"delivery":[33],"system,":[34],"which":[35,54],"provide":[36],"immediate":[37],"relief.":[38],"Hence,":[39],"the":[40,70,160,164,187,196],"present":[41],"investigation":[42],"was":[43,172,190],"undertaken":[44],"with":[45,107,120,131,148],"view":[47,122],"develop":[49],"mouth-dissolving":[50],"tablets":[51,73,166],"oxcarbazepine,":[53],"offers":[55],"new":[57],"range":[58],"product":[60],"having":[61],"desired":[62],"characteristics":[63],"intended":[65],"benefits.":[66],"In":[67],"this":[68],"study,":[69],"mouth":[71,152],"dissolving":[72,153],"were":[74,118],"prepared":[75,119,167],"using":[76,168],"two":[77],"different":[78,115],"technologies,":[79],"direct":[80,90],"compression":[81,91],"method":[82,92],"solid":[84,129,169],"dispersion":[85,170],"technology.":[86],"Tablets":[87],"produced":[88],"by":[89],"contain":[93],"crospovidone":[94],"superdisintegrant":[97],"aspartame":[99],"sweetener.":[102],"Solid":[103],"dispersions":[104,130],"oxcarbazepine":[106,165],"polyvinylpyrrolidone":[108,132],"K-30":[109,133],"polyethylene":[111],"glycol":[112],"6000":[113],"weight":[116],"ratios":[117,136],"increase":[124],"its":[125],"water":[126],"solubility.":[127],"1:2":[135],"drug:":[138],"carrier":[139],"showed":[140,162],"maximum":[141],"drug":[142,183,188],"release":[143,189],"hence,":[145],"compressed":[146],"along":[147],"other":[149],"excipients":[150],"tablet.":[154,199],"The":[155],"results":[156],"compared":[157],"for":[158],"both":[159],"technologies":[161],"that":[163],"technology":[171],"found":[173,191],"have":[175],"good":[176],"technological":[177],"properties":[178],"satisfying":[180],"reproducible":[182],"dissolution":[184],"profiles.":[185],"Moreover":[186],"be":[193],"comparable":[194],"marketed":[197],"dispersible":[198]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":3}],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2016-06-24T00:00:00"}